EligibleTrials

Clinical trials recruiting for Advanced Ovarian Carcinoma

5
Recruiting trials
15
US states with sites
2
Countries
0%
Accept healthy volunteers

Phase breakdown

Phase 1 3Phase 2 2

Drugs and treatments being studied

InterventionTrials
Atezolizumab1
Cabozantinib S-malate1
Devimistat1
Fluorouracil1
Gemcitabine Hydrochloride1
Hydroxychloroquine1
NKT39641
Nab-paclitaxel1
OATD-021

Where trials are recruiting (top US states)

StateRecruiting trials
Florida2
Texas2
Arkansas1
California1
Colorado1
Georgia1
Illinois1
Kansas1
Massachusetts1
New Jersey1
North Dakota1
Pennsylvania1

Top cities

Atlanta, Georgia 1Augusta, Georgia 1Austin, Texas 1Boston, Massachusetts 1Charlottesville, Virginia 1Chicago, Illinois 1Dallas, Texas 1Denver, Colorado 1Fairfax, Virginia 1Fairway, Kansas 1

Self-screener

Recruiting trials

Related conditions

Trials recruiting for Advanced Ovarian Carcinoma often also study these conditions. Each links to its own recruiting-trial list.

Metastatic Ovarian Carcinoma 5Pancreatic cancer 870Lung cancer 2180Advanced Renal Cell Carcinoma 6Advanced Pancreatic Carcinoma 5Advanced Endometrial Carcinoma 4Advanced Colorectal Carcinoma 8Stage IV Ovarian Cancer AJCC v8 4Stage III Ovarian Cancer AJCC v8 3Metastatic Renal Cell Carcinoma 8

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Advanced Ovarian Carcinoma trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.